Stout and Stumpf [32] reported that finasteride and other antiandrogens, such as flutamide, remain potential second-line agents for FPHL and may be an option for women who do not respond to or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback